106 related articles for article (PubMed ID: 15657205)
1. Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation.
Kim JW; Park CG; Seo HS; Oh DJ
Heart; 2005 Feb; 91(2):e15. PubMed ID: 15657205
[TBL] [Abstract][Full Text] [Related]
2. Coronary vasospasm and aborted sudden death treated with an implantable defibrillator and stenting.
Fiocca L; Di Biasi M; Bruno N; Ciuffreda M; Zumbo F; Mangiameli D; Montenero AS
Ital Heart J; 2002 Apr; 3(4):270-3. PubMed ID: 12025377
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
[TBL] [Abstract][Full Text] [Related]
4. Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry.
Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
Catheter Cardiovasc Interv; 2005 Oct; 66(2):173-7. PubMed ID: 16144017
[TBL] [Abstract][Full Text] [Related]
5. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.
Halkin A; Mehran R; Casey CW; Gordon P; Matthews R; Wilson BH; Leon MB; Russell ME; Ellis SG; Stone GW
Am Heart J; 2005 Dec; 150(6):1163-70. PubMed ID: 16338253
[TBL] [Abstract][Full Text] [Related]
6. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
Ellis SG; Colombo A; Grube E; Popma J; Koglin J; Dawkins KD; Stone GW
J Am Coll Cardiol; 2007 Mar; 49(10):1043-51. PubMed ID: 17349883
[TBL] [Abstract][Full Text] [Related]
7. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
Krucoff MW; Kereiakes DJ; Petersen JL; Mehran R; Hasselblad V; Lansky AJ; Fitzgerald PJ; Garg J; Turco MA; Simonton CA; Verheye S; Dubois CL; Gammon R; Batchelor WB; O'Shaughnessy CD; Hermiller JB; Schofer J; Buchbinder M; Wijns W;
J Am Coll Cardiol; 2008 Apr; 51(16):1543-52. PubMed ID: 18420096
[TBL] [Abstract][Full Text] [Related]
8. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
Ahmed WH
Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
[TBL] [Abstract][Full Text] [Related]
9. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
[TBL] [Abstract][Full Text] [Related]
10. Images in cardiovascular medicine. Coronary spasm resistant to intracoronary nitrates following successful stent implantation.
Tarantini G; Cardaioli P; Chioin R
Ital Heart J; 2001 Nov; 2(11):858-9. PubMed ID: 11770873
[No Abstract] [Full Text] [Related]
11. Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.
Lasala JM; Cox DA; Morris DL; Breall JA; Mahoney PD; Horwitz PA; Shaw D; Hood KL; Mandinov L; Dawkins KD
Am J Cardiol; 2009 Jun; 103(12):1663-71. PubMed ID: 19539073
[TBL] [Abstract][Full Text] [Related]
12. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
[TBL] [Abstract][Full Text] [Related]
14. Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).
Grube E; Silber S; Hauptmann KE; Buellesfeld L; Mueller R; Lim V; Gerckens U; Russell ME
Am J Cardiol; 2005 Jul; 96(1):79-82. PubMed ID: 15979439
[TBL] [Abstract][Full Text] [Related]
15. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS
Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
[TBL] [Abstract][Full Text] [Related]
18. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
Grube E; Dawkins KD; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Buellesfeld L; Koglin J; Russell ME
Eur Heart J; 2007 Nov; 28(21):2578-82. PubMed ID: 17938126
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
20. Coronary collateral function long after drug-eluting stent implantation.
Meier P; Zbinden R; Togni M; Wenaweser P; Windecker S; Meier B; Seiler C
J Am Coll Cardiol; 2007 Jan; 49(1):15-20. PubMed ID: 17207716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
